 Heubach Colorants India Ltd Q2 FY2026 PAT at Rs. 16.28 crores
Heubach Colorants India Ltd Q2 FY2026 PAT at Rs. 16.28 crores Indiabulls Ltd Q2 FY2025-26 consolidated profit at Rs. 0.71 crore
Indiabulls Ltd Q2 FY2025-26 consolidated profit at Rs. 0.71 crore LKP Securities Ltd consolidated Q2FY26 PAT lower at Rs. 2.66 crore
LKP Securities Ltd consolidated Q2FY26 PAT lower at Rs. 2.66 crore NTPC Green Energy Ltd Signs MoU with CtrlS Datacenter Limited for development of RE Projects
NTPC Green Energy Ltd Signs MoU with CtrlS Datacenter Limited for development of RE Projects Lemon Tree Hotels signs 11th property in Punjab
Lemon Tree Hotels signs 11th property in Punjab 
              The Initial Public Offering (IPO) of Claris Lifesciences Limited will open for subscription by investors on November 24, 2010. The company is coming out with public issue of equity shares of Rs.10 each for cash aggregating to Rs.300 crores.
The 100% book building issue is priced in a price band of Rs.278 to Rs.293. The Minimum Order Quantity is 22 Equity Shares and in multiples of 22 Equity Shares. The Maximum Subscription Amount for Retail Investor is Rs.200000.
The Rating Agency Fitch Ratings India Private Limited has assigned IPO Grading of IPO Grade 3.
Enam Securities Private Limited, Edelweiss Capital Limited, JM Financial Consultants Private Limited and ICICI Securities Limited are the Book Running Lead Managers to the IPO. Edelweiss Securities Limited and JM Financial Services Private Limited are the Syndicate Members to the IPO.
Link Intime India Private Limited is the registrar to the company.
The IPO closes for subscription on November 26, 2010.